TFS Capital’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,531
Closed -$971K 441
2017
Q2
$971K Buy
5,531
+4,127
+294% +$587K 0.38% 38
2017
Q1
$169K Buy
1,404
+419
+43% +$43.6K 0.05% 525
2016
Q4
$96K Sell
985
-374
-28% -$34.3K 0.03% 646
2016
Q3
$128K Sell
1,359
-7,331
-84% -$735K 0.03% 615
2016
Q2
$936K Sell
8,690
-4,696
-35% -$550K 0.17% 191
2016
Q1
$1.61M Buy
13,386
+7,310
+120% +$768K 0.23% 117
2015
Q4
$724K Sell
6,076
-17,082
-74% -$2.2M 0.08% 352
2015
Q3
$3.95M Buy
23,158
+2,318
+11% +$444K 0.38% 49
2015
Q2
$4.04M Buy
20,840
+13,678
+191% +$2.54M 0.39% 49
2015
Q1
$1.06M Buy
7,162
+3,369
+89% +$513K 0.1% 325
2014
Q4
$592K Buy
+3,793
New +$546K 0.06% 534
2014
Q2
Sell
-3,797
Closed -$465K 1427
2014
Q1
$465K Sell
3,797
-7,531
-66% -$816K 0.03% 763
2013
Q4
$1.2M Buy
11,328
+9,659
+579% +$937K 0.06% 488
2013
Q3
$187K Buy
+1,669
New +$189K 0.01% 1283

Other funds holding SRGA

TFS Capital's SRGA Position: Q3 2017 in Review

TFS Capital sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2017, closing a stake of 5,531 shares — an estimated $971K sold.

TFS Capital first reported a position in SRGA in Q3 2013 and held it in 14 quarters. The position peaked at $4.04M in Q2 2015. 103 funds tracked by Wall St. Rank hold SRGA as of Q3 2017.

  • TFS Capital reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 5,531 Surgalign Holdings, Inc. Common Stock shares in Q3 2017, an estimated $971K.
  • TFS Capital first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2013 and held it in 14 quarters.
  • TFS Capital's Surgalign Holdings, Inc. Common Stock position peaked at $4.04M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.